nach oben

Current Bladder Dysfunction Reports

Erschienen in:

13.02.2017 | Overactive Bladder (U Lee, Section Editor)

Outcomes for Intermittent Neuromodulation as a Treatment for Overactive Bladder

verfasst von: Laura N. Nguyen, M. Lira Chowdhury, Jason P. Gilleran

Erschienen in: Current Bladder Dysfunction Reports | Ausgabe 1/2017

Einloggen, um Zugang zu erhalten

Abstract

Purpose of Review

In this review, we describe the history and basic science behind intermittent neuromodulation, specifically of the tibial nerve and its neuroanatomic suitability for this approach, as well as the logistics, efficacy, and advantages of peripheral tibial nerve stimulation (PTNS) in both idiopathic and neurogenic overactive bladder (OAB) populations. We also discuss the less commonly used sacral, pudendal, and genital nerves as a means of intermittent neuromodulation for the management of OAB.

Recent Findings

Intermittent neuromodulation in the form of PTNS is approved as a third-line treatment of OAB, which affects upwards of 16% of the population of the USA.

Summary

Several studies and clinical trials have demonstrated the effectiveness of PTNS in treating OAB, with the benefit of decreased cost and invasiveness compared to chronic, implantable neurostimulators. This has been explored in various patient populations including patients with idiopathic and neurogenic detrusor overactivity.

MacDiarmid SA, Peters KM, Shobeiri SA, Wooldridge LS, Rovner ES, Leong FC, et al. Long-term durability of percutaneous tibial nerve stimulation for the treatment of overactive bladder. J Urol. 2010;183(1):234–40. doi:10.1016/j.juro.2009.08.160.CrossRefPubMed

Eftekhar T, Teimoory N, Miri E, Nikfallah A, Naemi M, Ghajarzadeh M. Posterior tibial nerve stimulation for treating neurologic bladder in women: a randomized clinical trial. Acta Med Iran. 2014;52(11):816–21.PubMed

McPherson A. The effects of somatic stimuli on the bladder in the cat. J Physiol. 1966;185(1):185–96.CrossRefPubMedPubMedCentral

McPherson A. Vesico-somatic reflexes in the chronic spinal cat. J Physiol. 1966;185(1):197–204.CrossRefPubMedPubMedCentral

Sato A, Sato Y, Schmidt RF, Torigata Y. Somato-vesical reflexes in chronic spinal cats. J Auton Nerv Syst. 1983;7:351–62. doi:10.1016/0165-1838(83)90088-7.CrossRefPubMed

McGuire E, Morrissey S, Zhang S, Horwinski E. Control of reflex detrusor activity in normal instability by electrical stimulation. J Urol. 1983;129(1):197–9.PubMed

McGuire EJ, Zhang SC, Horwinski ER, Lytton B. Treatment of motor and sensory detrusor instability by electrical stimulation. J Urol. 1983;129(1):78–9.PubMed

Tai C, Shen B, Chen M, Wang J, Roppolo JR, Groat WC. Prolonged poststimulation inhibition of bladder activity induced by tibial nerve stimulation in cats. Am J Physiol Ren Physiol. 2011;300(2):F385–F92. doi:10.1152/ajprenal.00526.2010.CrossRef

Kovacevic M, Yoo PB. Reflex neuromodulation of bladder function elicited by posterior tibial nerve stimulation in anesthetized rats. Am J Physiol Ren Physiol. 2015;308(4):F320–9. doi:10.1152/ajprenal.00212.2014.CrossRef

10.

Choudhary M, van Mastrigt R, van Asselt E. Inhibitory effects of tibial nerve stimulation on bladder neurophysiology in rats. Springer Plus. 2016;5:35. doi:10.1186/s40064-016-1687-6.CrossRefPubMedPubMedCentral

11.

McGill MJ, Gill WM. Temporal pattern of stimulation modulates reflex bladder activation by pudendal nerve stimulation. Neurourol Urodyn. 2016;35:882–7. doi:10.1002/nau.22822.CrossRef

12.

Herbison GP, Arnold EP. Sacral neuromodulation with implanted devices for urinary storage and voiding dysfunction in adults. Cochrane Database Syst Rev. 2009;Suppl 2:CD004202. doi:10.1002/14651858.CD004202.pub2.

13.

• Amarenco G, Ismael SS, Even-Schneider A, Raibaut P, Demaille-Wlodyka S, Parratte B, et al. Urodynamic effect of acute transcutaneous posterior tibial nerve stimulation in overactive bladder. J Urol. 2003;169(6):2210–5. doi:10.1097/01.ju.0000067446.17576.bd. Forty-four patients with neurogenic bladder were treated with acute transcutaneous posterior tibial nerve stimulation and cystometric changes were recorded. An increase in the overall cystometric capacity and volume at first detrusor contraction was demonstrated in this population. CrossRefPubMed

14.

Peters KM, Carrico DJ, MacDiarmid SA, Wooldridge LS, Khan AU, McCoy CE, et al. Sustained therapeutic effects of percutaneous tibial nerve stimulation: 24-month results of the STEP study. Neurourol Urodyn. 2013;32(1):24–9. doi:10.1002/nau.22266.CrossRefPubMed

15.

Martinson M, MacDiarmid S, Black E. Cost of neuromodulation therapies for overactive bladder: percutaneous tibial nerve stimulation versus sacral nerve stimulation. J Urol. 2013;189(1):210–6. doi:10.1016/j.juro.2012.08.085.CrossRefPubMed

16.

Robinson DJP, Cardozo L. What’s needling us about the management of refractory overactive bladder? An economic analysis of the use of percutaneous nerve stimulation and botulinum toxin. Neurourol Urodyn. 2010;29(6):805–1255.CrossRef

17.

Peters K, Carrico D, Burks F. Validation of a sham for percutaneous tibial nerve stimulation (PTNS). Neurourol Urodyn. 2009;28(1):58–61. doi:10.1002/nau.20585.CrossRefPubMed

18.

Finazzi-Agro E, Petta F, Sciobica F, Pasqualetti P, Musco S, Bove P. Percutaneous tibial nerve stimulation effects on detrusor overactivity incontinence are not due to a placebo effect: a randomized, double-blind, placebo controlled trial. J Urol. 2010;184(5):2001–6. doi:10.1016/j.juro.2010.06.113.CrossRefPubMed

19.

• Peters KM, Macdiarmid SA, Wooldridge LS, Leong FC, Shobeiri SA, Rovner ES, et al. Randomized trial of percutaneous tibial nerve stimulation versus extended-release tolterodine: results from the overactive bladder innovative therapy trial. J Urol. 2009;182(3):1055–61. doi:10.1016/j.juro.2009.05.045. This randomized controlled trial compared PTNS to oral anticholinergic medication (extended-release tolteridine). Both arms had statistically significant improvements in symptoms, although PTNS had a 79.5% cure/improvement versus 54.8% with pharmacotherapy. CrossRefPubMed

20.

Zecca C, Digesu GA, Robshaw P, Puccini F, Khullar V, Tubaro A, et al. Motor and sensory responses after percutaneous tibial nerve stimulation in multiple sclerosis patients with lower urinary tract symptoms treated in daily practice. Eur J Neurol. 2014;21(3):506–11. doi:10.1111/ene.12339.CrossRefPubMed

21.

Burton C, Sajja A, Latthe PM. Effectiveness of percutaneous posterior tibial nerve stimulation for overactive bladder: a systematic review and meta-analysis. Neurourol Urodyn. 2012;31(8):1206–16. doi:10.1002/nau.22251.CrossRefPubMed

22.

van Balken MR, Vandoninck V, Gisolf KW, Vergunst H, Kiemeney LA, Debruyne FM, et al. Posterior tibial nerve stimulation as neuromodulative treatment of lower urinary tract dysfunction. J Urol. 2001;166(3):914–8.CrossRefPubMed

23.

Govier F, Litwiller S, Nitti V, Kreder KJ, Rosenblatt P. Percutaneous afferent neuromodulation for the refractory overactive bladder: results of a multicenter study. J Urol. 2001;165:1193–8.CrossRefPubMed

24.

• Peters KM, Carrico DJ, Perez-Marrero RA, Khan AU, Wooldridge LS, Davis GL, et al. Randomized trial of percutaneous tibial nerve stimulation versus sham efficacy in the treatment of overactive bladder syndrome: results from the SUmiT trial. J Urol. 2010;183(4):1438–43. doi:10.1016/j.juro.2009.12.036. This randomized controlled trial compared PTNS to sham treatment. Quality of life questionnaires and 3-day diaries were completed at baseline and at 13 weeks. At 13 weeks, there was a reported 54.5% improved response compared to 20.9% in the sham. This was the first level 1 evidence supporting PTNS as a therapeutic agent for overactive bladder. CrossRefPubMed

25.

Peters KM, Carrico DJ, Wooldridge LS, Miller CJ, MacDiarmid SA. Percutaneous tibial nerve stimulation for the long-term treatment of overactive bladder: 3-year results of the STEP study. J Urol. 2013;189(6):2194–201. doi:10.1016/j.juro.2012.11.175.CrossRefPubMed

26.

Yoong W, Shah P, Dadswell R, Green L. Sustained effectiveness of percutaneous tibial nerve stimulation for overactive bladder syndrome: 2-year follow-up of positive responders. Int Urogynecol J. 2013;24(5):795–9. doi:10.1007/s00192-012-1936-3.CrossRefPubMed

27.

van der Pal F, van Balken MR, Heesakkers JP, Debruyne FM, Bemelmans BL. Percutaneous tibial nerve stimulation in the treatment of refractory overactive bladder syndrome: is maintenance treatment necessary? BJU Int. 2006;97(3):547–50. doi:10.1111/j.1464-410X.2006.06055.x.CrossRefPubMed

28.

Maurelli V, Petta F, Carsillo G, Miano R, Lamorte F, Perugia C, et al. What to do if percutaneous tibial nerve stimulation (PTNS) works? A pilot study on home-based transcutaneous tibial nerve stimulation. Urologia. 2012;79(19):86–90. doi:10.5301/RU.2012.9366.PubMed

29.

Janssen DA, Farag F, Heesakkers JP. Urgent-SQ implant in treatment of overactive bladder syndrome: 9-year follow-up study. Neurourol Urodyn. 2013;32(5):472–5. doi:10.1002/nau.22322.CrossRefPubMed

30.

Fjorback MV, van Rey FS, van der Pal F, Rijkhoff NJ, Petersen T, Heesakkers JP. Acute urodynamic effects of posterior tibial nerve stimulation on neurogenic detrusor overactivity in patients with MS. Eur Urol. 2007;51(2):464–70. doi:10.1016/j.eururo.2006.07.024. discussion 71–2.CrossRefPubMed

31.

Gobbi C, Digesu GA, Khullar V, El Neil S, Caccia G, Zecca C. Percutaneous posterior tibial nerve stimulation as an effective treatment of refractory lower urinary tract symptoms in patients with multiple sclerosis: preliminary data from a multicentre, prospective, open label trial. Mult Scler. 2011;17(12):1514–9. doi:10.1177/1352458511414040.CrossRefPubMed

32.

Kabay S, Canbaz Kabay S, Yucel M, Ozden H, Yilmaz Z, Aras O, et al. The clinical and urodynamic results of a 3-month percutaneous posterior tibial nerve stimulation treatment in patients with multiple sclerosis-related neurogenic bladder dysfunction. Neurourol Urodyn. 2009;28(8):964–8. doi:10.1002/nau.20733.CrossRefPubMed

33.

de Seze M, Raibaut P, Gallien P, Even-Schneider A, Denys P, Bonniaud V, et al. Transcutaneous posterior tibial nerve stimulation for treatment of the overactive bladder syndrome in multiple sclerosis: results of a multicenter prospective study. Neurourol Urodyn. 2011;30(3):306–11. doi:10.1002/nau.20958.CrossRefPubMed

34.

Kabay S, Canbaz Kabay S, Cetiner M, Mestan E, Sevim M, Ayas S, et al. The clinical and urodynamic results of percutaneous posterior tibial nerve stimulation on neurogenic detrusor overactivity in patients with Parkinson’s disease. J Urol. 2016;87:76–81. doi:10.1016/j.urology.2015.09.026.CrossRef

35.

Chen G, Liao L, Li Y. The possible role of percutaneous tibial nerve stimulation using adhesive skin surface electrodes in patients with neurogenic detrusor overactivity secondary to spinal cord injury. Int Urol Nephrol. 2015;47(3):451–5. doi:10.1007/s11255-015-0911-6.CrossRefPubMed

36.

Monteiro ES, de Carvalho LB, Fukujima MM, Lora MI, do Prado GF. Electrical stimulation of the posterior tibialis nerve improves symptoms of poststroke neurogenic overactive bladder in men: a randomized controlled trial. Urology. 2014;84(3):509–14. doi:10.1016/j.urology.2014.05.031.CrossRefPubMed

37.

Previnaire JG, Soler JM, Perrigot M, Boileau G, Delahaye H, Schumacker P, et al. Short-term effect of pudendal nerve electrical stimulation on detrusor hyperreflexia in spinal cord injury patients: importance of current strength. Paraplegia. 1996;34:95–9.CrossRefPubMed

38.

Lee YH, Creasey GH. Self-controlled dorsal penile nerve stimulation to inhibit bladder hyperreflexia in incomplete spinal cord injury: a case report. Arch Phys Med Rehabil. 2002;83:273–7. doi:10.5535/arm.2011.35.5.605.CrossRefPubMed

39.

Okada N, Igawa Y, Ogawa A, Nishizawa O. Transcutaneous electrical stimulation of thigh muscles in the treatment of detrusor overactivity. Br J Urol. 1998;81:560–4.CrossRefPubMed

40.

Opisso E, Borau A, Rijkhoff NJ. Subject-controlled stimulation of dorsal genital nerve to treat neurogenic detrusor overactivity at home. Neurourol Urodyn. 2013;32(7):1004–9. doi:10.1002/nau.22359.CrossRefPubMed

41.

Van Breda HMK, Farag FF, Martens FMJ, Heesakkers JP FA, Rijkhoff NJM. Subject-controlled, on-demand, dorsal genital nerve stimulation to treat urgency urinary incontinence; a pilot. Front Neurosci. 2016. doi:10.3389/fnins.2016.00024.PubMedPubMedCentral

42.

Oerlemans DJ, van Voskuilen AC, Marcelissen T, Weil EH, de Bie RA, van Kerrebroeck PE. Is on-demand sacral neuromodulation in patients with OAB syndrome a feasible therapy regime? Neurourol Urodyn. 2011;30(8):1493–6. doi:10.1002/nau.21070.CrossRefPubMed

43.

Hoen LA t, Groen J, Scheepe JR, Blok BFM. Intermittent sacral neuromodulation for idiopathic urgency urinary incontinence in women. Neurourol Urodyn. 2015. doi:10.1002/nau.22938.

Titel: Outcomes for Intermittent Neuromodulation as a Treatment for Overactive Bladder
verfasst von: Laura N. Nguyen
M. Lira Chowdhury
Jason P. Gilleran
Publikationsdatum: 13.02.2017
Verlag: Springer US
Erschienen in: Current Bladder Dysfunction Reports / Ausgabe 1/2017
Print ISSN: 1931-7212
Elektronische ISSN: 1931-7220
DOI: https://doi.org/10.1007/s11884-017-0411-x

Neu im Fachgebiet Urologie

25.04.2024 | Nierenkarzinom | Nachrichten

Update Urologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

Outcomes for Intermittent Neuromodulation as a Treatment for Overactive Bladder

Abstract

Purpose of Review

Recent Findings

Summary

Neu im Fachgebiet Urologie

Adjuvante Immuntherapie verlängert Leben bei RCC

Bei Senioren mit Prostatakarzinom auf Anämie achten!

Stufenschema weist Prostatakarzinom zuverlässig nach

Harnwegsinfektprophylaxe: Es geht auch ohne Antibiotika

Update Urologie

Springer Medizin

Abstract

Purpose of Review

Recent Findings

Summary

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 1/2017

Cognitive Effects of Anticholinergics in the Geriatric Patient Population: Safety and Treatment Considerations

Pathophysiology of the Underactive Bladder: Evolving New Concepts

Urinary Tract Infection Rates and Mechanisms After OnabotulinumtoxinA Bladder Injection: a Review

An Update on the Management of Neurogenic Bladder

Sacral Neuromodulation for the Treatment of Pelvic Floor Disorders

Patient Satisfaction on Overactive Bladder Treatment

Neu im Fachgebiet Urologie

Adjuvante Immuntherapie verlängert Leben bei RCC

Bei Senioren mit Prostatakarzinom auf Anämie achten!

Stufenschema weist Prostatakarzinom zuverlässig nach

Harnwegsinfektprophylaxe: Es geht auch ohne Antibiotika

Update Urologie